Phase 3 Open-Label Study Evaluating the Efficacy and Safety of Mavacamten in Japanese Adults With Obstructive Hypertrophic Cardiomyopathy - The HORIZON-HCM Study.
Kitaoka H, Ieda M, Ebato M, Kozuma K, Takayama M, Tanno K, Komiyama N, Sakata Y, Maekawa Y, Minami Y, Ogimoto A, Takaya T, Yasuda S, Amiya E, Furukawa Y, Watanabe T, Hiraya D, Miyagoshi H, Kinoshita G, Reedy A, Hegde SM, Florea V, Izumi C.
Kitaoka H, et al. Among authors: maekawa y.
Circ J. 2024 Dec 25;89(1):130-138. doi: 10.1253/circj.CJ-24-0501. Epub 2024 Nov 7.
Circ J. 2024.
PMID: 39505542
Free article.
Clinical Trial.